Discovery of novel antitumor dibenzocyclooctatetraene derivatives and related biphenyls as potent inhibitors of NF-?B signaling pathway.

ABSTRACT: Several dibenzocyclooctatetraene derivatives (5-7) and related biphenyls (8-11) were designed, synthesized, and evaluated for inhibition of cancer cell growth and the NF-?B signaling pathway. Compound 5a, a dibenzocyclooctatetraene succinimide, was discovered as a potent inhibitor of the NF-?B signaling pathway with significant antitumor activity against several human tumor cell lines (GI?? 1.38-1.45 ?M) and was more potent than paclitaxel against the drug-resistant KBvin cell line. Compound 5a also inhibited LPS-induced NF-?B activation in RAW264.7 cells with an IC?? value of 0.52 ?M, prevented I?B-? degradation and p65 nuclear translocation, and suppressed LPS-induced NO production in a dose-dependent manner. The antitumor data in cellular assays indicated that relative positions and types of substituents on the dibenzocyclooctatetraene or acyclic biphenyl as well as torsional angles between the two phenyls are of primary importance to antitumor activity.

SUBMITTER: Yu FL 

PROVIDER: S-EPMC3899348 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature